Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZIMOR 20 CAPSULE 20 MG - HSA Drug Approval Details

Approvals/HSA/ZIMOR 20 CAPSULE 20 MG

Approved

THERAPEUTIC

ZIMOR 20 CAPSULE 20 MG

LABORATORIOS RUBIO SA (SPAIN)🇸🇬 Health Sciences Authority

Approval Date: Feb 12, 1999
Approval ID: 278537afbeb48ecf
Company: LABORATORIOS RUBIO SA (SPAIN)
Type: Therapeutic

Approval Details

Approval Id: 278537afbeb48ecf
Drug Name: ZIMOR 20 CAPSULE 20 MG
Product Name: ZIMOR 20 CAPSULE 20 MG
Approval Number: SIN10746P
Approval Date: 1999-02-12
Registrant: ZYFAS PHARMA PTE LTD
Licence Holder: ZYFAS PHARMA PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: A02BC01
Atc Item Name: omeprazole
Pharma Manufacturer Name: ZYFAS MEDICAL CO

Active Ingredients

OMEPRAZOLE

20 mg

OMEPRAZOLE

20 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 12, 1999

Approval ID

278537afbeb48ecf

Type

Therapeutic

Back to HSA Approvals